Effect of bisdemethoxycurcumin on staurosporine-induced apoptosis in cardiomyocytes
CSTR:
Author:
Affiliation:

(Department of Geriatrics, Xijing Hospital, the Fourth Military Medical University, Xi’an 710032, China)

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To determine the effect of bisdemethoxycurcumin (BDMC) on the apoptosis of primary cardiomyocytes induced by staurosporine (STS). Methods Myocardial cells were isolated from neonatal C57BL/6J mice and then primarily cultured. Then the obtained cells were divided into control group, STS treatment group, BDMC pretreatment+STS treatment group and BDMC pretreatment group. Cell viability, cell apoptosis, caspase-3 activity, and intracellular reactive oxygen species (ROS) level were measured by CCK-8 assay, TUNEL assay kit, caspase-3 activity assay kit and ROS assay kit, respectively. Results Pretreatment of 100 μmol/L BDMC resulted in significantly increased cell viability, obviously decreased caspase-3 activity, remarkably lowered apoptosis rate and notably reduced ROS level (P<0.05) in the cardiomyocytes. Conclusion BDMC can inhibit cell apoptosis through decreasing the intracellular ROS level in the cardiomyocytes, so as to protect the cells against STS-induced injury.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 06,2016
  • Revised:August 18,2016
  • Adopted:
  • Online: January 18,2017
  • Published:
Article QR Code